| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7e822fed60c6833e77f48a2843fb1e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9f630f5db00d39f4a3691854ce84ab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f709e845f0384bea14846db169fb3a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f885d1b2e0b3d4f677e6bb6de1fa4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_576f93beadcb07ee5d130a0d131da5f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-76 |
| filingDate |
2011-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194156877f74e3ad69d11f49a25cbd40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b69a8accc3f885de2ce3e6a3b4109f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d7c5bd57a69481a193bee1c661391eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3c910de9ec8a2afe54d95514bac00da |
| publicationDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8288365-B2 |
| titleOfInvention |
Phenazopyridine compounds |
| abstract |
The present invention is directed to substituted phenazopyridines represented by Formula I. The present invention also relates to the discovery that compounds of Formula I have increased bioavailability as compared to unconjugated phenazopyridine. |
| priorityDate |
2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |